Transgene SA (FRA:TGNA)

Transgene Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 19, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	225	90	138	165	248	138
Market Cap Growth	136.85%	-34.86%	-16.38%	-33.52%	79.73%	6.94%
Enterprise Value	239	111	124	138	218	134
Last Close Price	0.77	0.69	1.34	1.65	2.45	1.66
PS Ratio	29.71	14.13	17.44	15.93	14.38	14.41
PB Ratio	-62.45	5.90	8.82	4.35	3.69	2.72
P/TBV Ratio	-	5.93	8.87	4.36	3.69	2.73
EV/Sales Ratio	31.60	17.51	15.76	13.38	12.64	13.96
Debt / Equity Ratio	-8.62	0.68	1.11	0.36	0.25	0.36
Net Debt / Equity Ratio	-3.97	-0.41	0.10	-0.35	-0.49	-0.16
Net Debt / EBITDA Ratio	-0.41	0.18	-0.06	0.47	1.55	0.35
Net Debt / FCF Ratio	-0.59	0.24	-0.04	0.61	1.24	0.27
Asset Turnover	0.17	0.14	0.14	0.12	0.18	0.10
Quick Ratio	0.47	1.39	1.69	2.38	4.17	2.11
Current Ratio	0.54	1.48	1.79	3.64	4.27	2.25
Return on Equity (ROE)	-	-220.48%	-83.54%	-62.45%	-33.13%	-29.60%
Return on Assets (ROA)	-49.35%	-51.00%	-33.60%	-22.21%	-15.81%	-15.14%
Return on Capital Employed (ROCE)	-4406.30%	-126.50%	-85.30%	-55.70%	-27.20%	-33.90%
Earnings Yield	-16.34%	-37.85%	-16.21%	-19.91%	-7.88%	-12.50%
FCF Yield	-10.80%	-29.65%	-27.10%	-13.23%	-10.72%	-21.43%
Buyback Yield / Dilution	-30.91%	-15.98%	-1.09%	-9.21%	-11.04%	-0.36%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.